NCT01325415View on ClinicalTrials.gov

A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Amount of NKTR-118 in BloodVariation in the Heart's Electrical Cycle
Interventions
DRUG

NKTR-118

25 mg tablet

DRUG

moxifloxacin

400 mg tablet

DRUG

Placebo

tablet

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY